Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction

T. Ahmed, E. Russi, C. S. Kim, I. Danta

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We investigated the comparative effects of oral and inhaled verapamil on specific airway conductance (SGaw) and allergic bronchial reactivity. Ten asymptomatic subjects with ragweed hypersensitivity and a history of bronchial asthma were studied on four different days, without and with pre-treatments by oral (160 mg) or inhaled (20 mg) verapamil. Bronchial reactivity was measured as the cumulative provocative dose of ragweed antigen which caused a 35 percent decrease in SGaw, ie PD35. The amount of inhaled verapamil actually deposited in the tracheobronchial tree was estimated to be 0.56 mg. Mean SGaw was not affected by either mode of administration; mean SGaw (SE) was 0.13(.02) and 0.12(.02) L/sec-1 before and .14(.02) and 0.12(.02) L/sec-1 after oral and inhaled verapamil, respectively. Mean (SE) PD35 was reproducible on two control days, ie 0.9(.4) and 0.8(.4) breath units, respectively. Inhaled verapamil increased mean PD35 to 18.8(10.8) breath units (p < .02), while oral verapamil had no significant effect on mean PD35. This study demonstrates that route of administration of calcium antagonist verapamil is an important factor in protection against antigen-induced bronchoconstriction. Inhalation of verapamil appears to be more effective than oral administration.

Original languageEnglish
Pages (from-to)176-180
Number of pages5
JournalChest
Volume88
Issue number2
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Bronchoconstriction
Verapamil
Antigens
Ambrosia
Inhalation
Oral Administration
Hypersensitivity
Asthma
Calcium

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ahmed, T., Russi, E., Kim, C. S., & Danta, I. (1985). Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction. Chest, 88(2), 176-180.

Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction. / Ahmed, T.; Russi, E.; Kim, C. S.; Danta, I.

In: Chest, Vol. 88, No. 2, 01.01.1985, p. 176-180.

Research output: Contribution to journalArticle

Ahmed, T, Russi, E, Kim, CS & Danta, I 1985, 'Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction', Chest, vol. 88, no. 2, pp. 176-180.
Ahmed T, Russi E, Kim CS, Danta I. Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction. Chest. 1985 Jan 1;88(2):176-180.
Ahmed, T. ; Russi, E. ; Kim, C. S. ; Danta, I. / Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction. In: Chest. 1985 ; Vol. 88, No. 2. pp. 176-180.
@article{d656539e8be74c7384fe1fc2916393c9,
title = "Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction",
abstract = "We investigated the comparative effects of oral and inhaled verapamil on specific airway conductance (SGaw) and allergic bronchial reactivity. Ten asymptomatic subjects with ragweed hypersensitivity and a history of bronchial asthma were studied on four different days, without and with pre-treatments by oral (160 mg) or inhaled (20 mg) verapamil. Bronchial reactivity was measured as the cumulative provocative dose of ragweed antigen which caused a 35 percent decrease in SGaw, ie PD35. The amount of inhaled verapamil actually deposited in the tracheobronchial tree was estimated to be 0.56 mg. Mean SGaw was not affected by either mode of administration; mean SGaw (SE) was 0.13(.02) and 0.12(.02) L/sec-1 before and .14(.02) and 0.12(.02) L/sec-1 after oral and inhaled verapamil, respectively. Mean (SE) PD35 was reproducible on two control days, ie 0.9(.4) and 0.8(.4) breath units, respectively. Inhaled verapamil increased mean PD35 to 18.8(10.8) breath units (p < .02), while oral verapamil had no significant effect on mean PD35. This study demonstrates that route of administration of calcium antagonist verapamil is an important factor in protection against antigen-induced bronchoconstriction. Inhalation of verapamil appears to be more effective than oral administration.",
author = "T. Ahmed and E. Russi and Kim, {C. S.} and I. Danta",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "88",
pages = "176--180",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "2",

}

TY - JOUR

T1 - Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction

AU - Ahmed, T.

AU - Russi, E.

AU - Kim, C. S.

AU - Danta, I.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - We investigated the comparative effects of oral and inhaled verapamil on specific airway conductance (SGaw) and allergic bronchial reactivity. Ten asymptomatic subjects with ragweed hypersensitivity and a history of bronchial asthma were studied on four different days, without and with pre-treatments by oral (160 mg) or inhaled (20 mg) verapamil. Bronchial reactivity was measured as the cumulative provocative dose of ragweed antigen which caused a 35 percent decrease in SGaw, ie PD35. The amount of inhaled verapamil actually deposited in the tracheobronchial tree was estimated to be 0.56 mg. Mean SGaw was not affected by either mode of administration; mean SGaw (SE) was 0.13(.02) and 0.12(.02) L/sec-1 before and .14(.02) and 0.12(.02) L/sec-1 after oral and inhaled verapamil, respectively. Mean (SE) PD35 was reproducible on two control days, ie 0.9(.4) and 0.8(.4) breath units, respectively. Inhaled verapamil increased mean PD35 to 18.8(10.8) breath units (p < .02), while oral verapamil had no significant effect on mean PD35. This study demonstrates that route of administration of calcium antagonist verapamil is an important factor in protection against antigen-induced bronchoconstriction. Inhalation of verapamil appears to be more effective than oral administration.

AB - We investigated the comparative effects of oral and inhaled verapamil on specific airway conductance (SGaw) and allergic bronchial reactivity. Ten asymptomatic subjects with ragweed hypersensitivity and a history of bronchial asthma were studied on four different days, without and with pre-treatments by oral (160 mg) or inhaled (20 mg) verapamil. Bronchial reactivity was measured as the cumulative provocative dose of ragweed antigen which caused a 35 percent decrease in SGaw, ie PD35. The amount of inhaled verapamil actually deposited in the tracheobronchial tree was estimated to be 0.56 mg. Mean SGaw was not affected by either mode of administration; mean SGaw (SE) was 0.13(.02) and 0.12(.02) L/sec-1 before and .14(.02) and 0.12(.02) L/sec-1 after oral and inhaled verapamil, respectively. Mean (SE) PD35 was reproducible on two control days, ie 0.9(.4) and 0.8(.4) breath units, respectively. Inhaled verapamil increased mean PD35 to 18.8(10.8) breath units (p < .02), while oral verapamil had no significant effect on mean PD35. This study demonstrates that route of administration of calcium antagonist verapamil is an important factor in protection against antigen-induced bronchoconstriction. Inhalation of verapamil appears to be more effective than oral administration.

UR - http://www.scopus.com/inward/record.url?scp=0021843188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021843188&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 176

EP - 180

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -